CJC-1295 (without DAC) and Dutasteride Interaction

Monitor
Mechanism-based 51% confidence

CJC-1295 (without DAC) and Dutasteride have an interaction requiring monitoring for interaction with 51% confidence. Both CJC-1295 (without DAC) and Dutasteride can elevate estrogen. Combined estrogenic load increases risk of gynecomastia, water retention, and mood changes. Monitor estradiol levels and consider AI if needed. These compounds primarily affect different organ systems.

Compound Profiles

CJC-1295 (without DAC)

Short-Acting Growth Hormone Releasing Hormone Analog

Binds GHRH receptors on somatotroph cells in the pituitary gland, stimulating cAMP production and physiological GH pulses. The brief 30-minute half-life allows pulsatile release versus prolonged elevation.

Half-life: 30 minutes - 2 hours Typical dose: 100-300mcg per injection growth hormone, weight loss
ghrh receptor carcinogenic riskestrogenicinsulin disruptingteratogenic
View full profile

Dutasteride

Dual 5-Alpha Reductase Inhibitor | Hair Loss & BPH

Dutasteride competitively inhibits both the Type I and Type II isoforms of the enzyme 5-alpha reductase. Type II is the predominant isoform in the prostate and hair follicles, while Type I is found primarily in the skin, sebaceous glands, and liver.

Half-life: ~5 weeks (extremely long; active metabolite accumulation over months) Typical dose: 0.5mg/day hair loss
5 alpha reductase estrogenichepatotoxicteratogenic
View full profile

Combined Organ Load

GI Tract
low
Pituitary
low
Skin
low

Shared Safety Flags

2x 2 estrogenic compounds (CJC-1295 (without DAC), Dutasteride). Combined estrogen elevation — monitor E2 and consider aromatase inhibitor.
2x 2 compounds share the teratogenic safety flag (CJC-1295 (without DAC), Dutasteride). Monitor accordingly.

Frequently Asked Questions

Can I take CJC-1295 (without DAC) with Dutasteride?

Yes, but with caution. Both CJC-1295 (without DAC) and Dutasteride can elevate estrogen. Combined estrogenic load increases risk of gynecomastia, water retention, and mood changes. Monitor estradiol levels and consider AI if needed. Regular monitoring is advised.

Is CJC-1295 (without DAC) and Dutasteride safe together?

Based on pharmacological analysis, this combination is considered monitor. However, shared safety flags include: estrogenic, teratogenic. Monitor accordingly.

What are the interactions between CJC-1295 (without DAC) and Dutasteride?

Both CJC-1295 (without DAC) and Dutasteride can elevate estrogen. Combined estrogenic load increases risk of gynecomastia, water retention, and mood changes. Monitor estradiol levels and consider AI if needed. This assessment has 51% confidence and is inferred from pharmacological mechanism analysis.

How should I time CJC-1295 (without DAC) and Dutasteride?

CJC-1295 (without DAC) has a half-life of 30 minutes - 2 hours and Dutasteride has a half-life of ~5 weeks (extremely long; active metabolite accumulation over months). No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: CJC-1295 (without DAC) vs Dutasteride

This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.